Screening/Prevention Ovarian Cancer

Ovarian Cancer Clinical Trials: What, Where, Why (07-5-2017)

Pre-recorded webinar on Thursday, July 13th, 7–8 p.m. EST Have questions about ovarian cancer clinical trials? Join the National Ovarian Cancer Coalition® (NOCC) for an Ask the Expert session with Michael J. Birrer, MD, PhD, recognized nationally... Continue Reading

FDA Warns Against Ovarian Cancer Screening Tests (10-6-2016)

According to the US Food and Drug Administration (FDA) doctors and their patients should not use certain ovarian cancer screening tests because of inaccurate results. Screening tests are designed to detect cancer in its earliest stages when it is most... Continue Reading

Counsyl Announces Major Oncology Expansion to Advance Genetic Screening for Cancer Risk (05-25-2016)

Counsyl launches oncology business unit, an expanded test to assess risk for inherited forms of cancer, and tools to improve genetic screening rates across the healthcare system Counsyl, a DNA testing and genetic counseling service, today announced its... Continue Reading

Personalized Screening Test for Ovarian Cancer Potentially Game-Changing, says GlobalData (05-18-2015)

   LONDON, UK (GlobalData), 12 May 2015 – The encouraging recent results of a 14-year study by the UK Collaborative Trial of Ovarian Cancer Screening could herald a radical departure from the approach established by other screening tests for... Continue Reading

Aspirin as Ovarian Cancer Prevention? Research Says Maybe (02-20-2014)

New evidence suggests that an aspirin a day may reduce the risk of ovarian cancer. But more research is needed before your doctor will routinely prescribe it for prevention. You may know that low doses of aspirin, taken daily, can help reduce the risk... Continue Reading

Oral Contraceptives and the Risk of Breast and Ovarian Cancer (11-20-2013)

Women with BRCA 1/2 mutations who use oral contraceptives (birth control pills) have a significantly reduced risk of ovarian cancer and a non-significantly increased risk of breast cancer, according to the results of a study published in the Journal... Continue Reading

Ovarian Cancer Rates Appeared to Drop Along with a Drop in the Use of Hormone Replacement Therapy (06-21-2013)

Ovarian rates began to decline faster in 2002, which is about the same time many older women stopped using hormone replacement therapy, according to the results of a study published in the Journal of Clinical Oncology. Hormone replacement therapy (HRT)... Continue Reading

Ovarian Cancer Rates Declining in Breast Cancer Survivors (02-7-2013)

The rate of second primary ovarian cancers after first primary breast cancer appears to be on the decline, according to the results of a study published in the Journal of Clinical Oncology. Each year in the United States, roughly 22,000 women are diagnosed... Continue Reading

Diabetes Drug May Help Prevent or Treat Ovarian Cancer (12-3-2012)

Metformin, a widely prescribed insulin-lowering drug for diabetes, has been associated with survival in ovarian cancer and is worthy of further study, as it may be considered for the prevention or treatment of ovarian cancer, according to the results... Continue Reading

Aspirin May Reduce Risk of Serous Ovarian Cancer (10-18-2012)

Women who regularly use aspirin may have a decreased risk of developing serous ovarian cancer, according to the results of a study published in Acta Obstetricia et Gynecologica Scandinavica. Ovarian cancer has the highest mortality rate of all gynecologic... Continue Reading

Next Page »